Impact of dietary fat on gut microbiota and low-grade systemic inflammation: mechanisms and clinical implications on obesity

International Journal of Food Sciences and Nutrition

Volumn 69, Issue 2, 2018, Pages 125-143

  Cândido, Flávia Galvão ^a   Valente, Flávia Xavier ^a   Grześkowiak, Łukasz Marcin ^a   Moreira, Ana Paula Boroni ^b   Rocha, Daniela Mayumi Usuda Prado ^a   Alfenas, Rita de Cássia Gonçalves ^a  

^a FEDERAL UNIVERSITY OF VIÇOSA   (Brazil)

^b FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

Author keywords

High fat diets; lipopolysaccharide; metabolic endotoxemia; monounsaturated fatty acid; polyunsaturated fatty acids; probiotics

Indexed keywords

PROBIOTIC AGENT; SYNBIOTIC AGENT;

ANIMAL; BODY WEIGHT GAIN; DIET THERAPY; DYSBIOSIS; ENDOTOXEMIA; ENTERITIS; EVIDENCE BASED MEDICINE; HUMAN; IMMUNOLOGY; INTESTINE; INTESTINE FLORA; LIPID DIET; MICROBIOLOGY; OBESITY; PATHOPHYSIOLOGY; PERMEABILITY;

ANIMALS; DIET, HIGH-FAT; DYSBIOSIS; ENDOTOXEMIA; ENTERITIS; EVIDENCE-BASED MEDICINE; GASTROINTESTINAL MICROBIOME; HUMANS; INTESTINES; OBESITY; PERMEABILITY; PROBIOTICS; SYNBIOTICS; WEIGHT GAIN;

EID: 85021790576     PISSN: 09637486     EISSN: 14653478     Source Type: Journal    
DOI: 10.1080/09637486.2017.1343286     Document Type: Article

References (119)

1. Abbasi F, Blasey C, Reaven GM., 2013. Cardiometabolic risk factors and obesity: does it matter whether BMI or waist circumference is the index of obesity? Am J Clin Nutr. 98:637–640.
2. Abdullah A, Peeters A, de Courten M, Stoelwinder J., 2010. The magnitude of association between overweight and obesity and the risk of diabetes: a meta-analysis of prospective cohort studies. Diabetes Res Clin Pract. 89:309–319.
3. Alex S, Lichtenstein L, Dijk W, Mensink RP, Tan NS, Kersten S., 2014. ANGPTL4 is produced by entero-endocrine cells in the human intestinal tract. Histochem Cell Biol. 141:383–391.
4. An HM, Park SY, Lee DK, Kim JR, Cha MK, Lee SW, Lim HT, Kim KJ, Ha NJ., 2011. Antiobesity and lipid-lowering effects of Bifidobacterium spp. in high fat diet-induced obese rats. Lipids Health Dis. 10:116.
5. Anderson RC, Cookson AL, McNabb WC, Park Z, McCann MJ, Kelly WJ, Roy NC., 2010. Lactobacillus plantarum MB452 enhances the function of the intestinal barrier by increasing the expression levels of genes involved in tight junction formation. BMC Microbiol. 10:1–11.
6. Bäckhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, Gordon JI., 2004. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA. 101:15718–15723.
7. Bäckhed F, Manchester JK, Semenkovich CF, Gordon JI., 2007. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci USA. 104:979–984.
8. Belzer C, de Vos WM., 2012. Microbes inside-from diversity to function: the case of Akkermansia. ISME J. 6:1449–1458.
9. Berg RD., 1996. The indigenous gastrointestinal microflora. Trends Microbiol. 4:430–435.
10. Bergman EN., 1990. Energy contributions of volatile fatty acids from the gastrointestinal tract in various species. Physiol Rev. 70:567–590.
11. Blaut M, Klaus S., 2012. Intestinal microbiota and obesity. Handb Exp Pharmacol. 251–273.
12. Bogunovic M, Davé SH, Tilstra JS, Chang DTW, Harpaz N, Xiong H, Mayer LF, Plevy SE., 2007. Enteroendocrine cells express functional Toll-like receptors. Am J Physiol Gastrointest Liver Physiol. 292:G1770–G1783.
13. Brun P, Castagliuolo I, Di Leo V, Buda A, Pinzani M, Palù G, Martines D., 2007. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol. 292:G518–G525.
14. Caesar R, Nygren H, Orešič M, Bäckhed F., 2016. Interaction between dietary lipids and gut microbiota regulates hepatic cholesterol metabolism. J Lipid Res. 57:474–481.
15. Calder PC., 2013. n-3 fatty acids, inflammation and immunity: new mechanisms to explain old actions. Proc Nutr Soc. 72:326–336.
16. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, et al. 2007. Metabolic Endotoxemia Initiates obesity and insulin resistance. Diabetes. 56:1761–1772.
17. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, Burcelin R., 2008. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes. 57:1470–1481.
18. Cani PD, Delzenne NM., 2007. Gut microflora as a target for energy and metabolic homeostasis. Curr Opin Clin Nutr Metab Care. 10:729–734.
19. Cani PD, Delzenne NM., 2011. The gut microbiome as therapeutic target. Pharmacol Ther. 130:202–212.
20. Cani PD, Geurts L, Matamoros S, Plovier H, Duparc T., 2014. Glucose metabolism: focus on gut microbiota, the endocannabinoid system and beyond. Diabetes Metab. 40:246–257.
21. Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, Geurts L, Naslain D, Neyrinck A, Lambert DM, et al. 2009. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut. 58:1091–1103.
22. Cano PG, Santacruz A, Trejo FM, Sanz Y., 2013. Bifidobacterium CECT 7765 improves metabolic and immunological alterations associated with obesity in high-fat diet-fed mice. Obesity (Silver Spring). 21:2310–2321.
23. Collado MC, Isolauri E, Laitinen K, Salminen S., 2008. Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women. Am J Clin Nutr. 88:894–899.
24. Cotillard A, Kennedy SP, Kong LC, Prifti E, Pons N, Le Chatelier E, Almeida M, Quinquis B, Levenez F, Galleron N, et al. 2013. Dietary intervention impact on gut microbial gene richness. Nature. 500:585–588.
25. Daniel H, Gholami AM, Berry D, Desmarchelier C, Hahne H, Loh G, Mondot S, Lepage P, Rothballer M, Walker A, et al. 2014. High-fat diet alters gut microbiota physiology in mice. ISME J. 8:295–308.
26. Davis CD., 2016. The gut microbiome and its role in obesity. Nutr Today. 51:167–174.
27. de Heredia FP, Gómez-Martínez S, Marcos A., 2012. Obesity, inflammation and the immune system. Proc Nutr Soc. 71:332–338.
28. de La Serre CB, Ellis CL, Lee J, Hartman AL, Rutledge JC, Raybould HE., 2010. Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol Gastrointest Liver Physiol. 299:G440–G448.
29. de Wit N, Derrien M, Bosch-Vermeulen H, Oosterink E, Keshtkar S, Duval C, de Vogel-van den Bosch J, Kleerebezem M, Muller M, van der Meer R, et al. 2012. Saturated fat stimulates obesity and hepatic steatosis and affects gut microbiota composition by an enhanced overflow of dietary fat to the distal intestine. AJP Gastrointest Liver Physiol. 303:G589–G599.
30. Derrien M, Vaughan EE, Plugge CM, de Vos WM., 2004. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int J Syst Evol Microbiol. 54:1469–1476.
31. Desbois AP, Lebl T, Yan L, Smith VJ., 2008. Isolation and structural characterisation of two antibacterial free fatty acids from the marine diatom, Phaeodactylum tricornutum. Appl Microbiol Biotechnol. 81:755–764.
32. Desbois AP, Smith VJ., 2010. Antibacterial free fatty acids: activities, mechanisms of action and biotechnological potential. Appl Microbiol Biotechnol. 85:1629–1642.
33. Devkota S, Wang Y, Musch MW, Leone V, Fehlner-Peach H, Nadimpalli A, Antonopoulos DA, Jabri B, Chang EB., 2012. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10–/– mice. Nature. 487:104–108.
34. Dilzer A, Park Y., 2012. Implication of conjugated linoleic acid (CLA) in human health. Crit Rev Food Sci Nutr. 52:488–513.
35. Dorresteijn JN, Visseren FLJ, Spiering W., 2012. Mechanisms linking obesity to hypertension. Obes Rev. 13:17–26.
36. El Aidy S, Merrifield CA, Derrien M, van Baarlen P, Hooiveld G, Levenez F, Doré J, Dekker J, Holmes E, Claus SP, et al. 2013. The gut microbiota elicits a profound metabolic reorientation in the mouse jejunal mucosa during conventionalisation. Gut. 62:1306–1314.
37. Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, Guiot Y, Derrien M, Muccioli GG, Delzenne NM, et al. 2013. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci USA. 110:9066–9071.
38. Everard A, Lazarevic V, Derrien M, Girard M, Muccioli GG, Muccioli GM, Neyrinck AM, Possemiers S, Van Holle A, François P, et al. 2011. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes. 60:2775–2786.
39. Feldlaufer MF, Knox DA, Lusby WR, Shimanuki H., 1993. Antimicrobial activity of fatty acids against Bacillus larvae, the causative agent of American foulbrood disease. Apidologie. 24:5.
40. Gabert L, Vors C, Louche-Pélissier C, Sauvinet V, Lambert-Porcheron S, Drai J, Laville M, Désage M, Michalski M-C., et al. 2011. 13C tracer recovery in human stools after digestion of a fat-rich meal labelled with [1,1,1-13C3]tripalmitin and [1,1,1-13C3]triolein. Rapid Commun Mass Spectrom RCM. 25:2697–2703.
41. Galbraith H, Miller TB, Paton AM, Thompson JK., 1971. Antibacterial activity of long chain fatty acids and the reversal with calcium, magnesium, ergocalciferol and cholesterol. J Appl Bacteriol. 34:803–813.
42. Geurts L, Lazarevic V, Derrien M, Everard A, Van Roye M, Knauf C, Valet P, Girard M, Muccioli GG, François P, et al. 2011. Altered gut microbiota and endocannabinoid system tone in obese and diabetic leptin-resistant mice: impact on apelin regulation in adipose tissue. Front Microbiol. 2:149.
43. Ghoshal S, Witta J, Zhong J, de Villiers W, Eckhardt E., 2009. Chylomicrons promote intestinal absorption of lipopolysaccharides. J Lipid Res. 50:90–97.
44. Gómez Candela C, Bermejo López LM, Loria Kohen V., 2011. Importance of a balanced omega 6/omega 3 ratio for the maintenance of health: nutritional recommendations. Nutr Hosp. 26:323–329.
45. Guerciolini R., 1997. Mode of action of orlistat. Int J Obes Relat Metab Disord. 21 Suppl 3:S12–S23.
46. Harvey AE, Lashinger LM, Hursting SD., 2011. The growing challenge of obesity and cancer: an inflammatory issue. Ann N Y Acad Sci. 1229:45–52.
47. Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T, Thaiss CA, Kau AL, Eisenbarth SC, Jurczak MJ, et al. 2012. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature. 482:179–185.
48. Hildebrandt MA, Hoffmann C, Sherrill-Mix SA, Keilbaugh SA, Hamady M, Chen Y-Y, Knight R, Ahima RS, Bushman F, Wu GD, et al. 2009. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology. 137:1716–1724.
49. Honda KL., 2014. Effect of omega-3 fatty acids on toll-like receptor 4-mediated macrophage inflammation and its regulation. Tufts University.
50. Huang CB, George B, Ebersole JL., 2010. Antimicrobial activity of n-6, n-7 and n-9 fatty acids and their esters for oral microorganisms. Arch Oral Biol. 55:555–560.
51. Huang S, Rutkowsky JM, Snodgrass RG, Ono-Moore KD, Schneider DA, Newman JW, Adams SH, Hwang DH., 2012. Saturated fatty acids activate TLR-mediated proinflammatory signaling pathways. J Lipid Res. 53:2002–2013.
52. Hulston CJ, Churnside AA, Venables MC., 2015. Probiotic supplementation prevents high-fat, overfeeding-induced insulin resistance in human subjects. Br J Nutr. 113:596–602.
53. Jayasinghe TN, Chiavaroli V, Holland DJ, Cutfield WS, O’sullivan JM., 2016. The new era of treatment for obesity and metabolic disorders: evidence and expectations for gut microbiome transplantation. Front Cell Infect Microbiol. 6:15.
54. Ji Y, Sakata Y, Tso P., 2011. Nutrient-induced inflammation in the intestine. Curr Opin Clin Nutr Metab Care. 14:315–321.
55. Karimi G, Sabran MR, Jamaluddin R, Parvaneh K, Mohtarrudin N, Ahmad Z, Khazaai H, Khodavandi A., 2015. The anti-obesity effects of Lactobacillus casei strain Shirota versus Orlistat on high fat diet-induced obese rats. Food Nutr Res. 59:29273.
56. Karlsson CLJ, Onnerfält J, Xu J, Molin G, Ahrné S, Thorngren-Jerneck K., 2012. The microbiota of the gut in preschool children with normal and excessive body weight. Obesity (Silver Spring). 20:2257–2261.
57. Krajmalnik-Brown R, Ilhan Z-E, Kang D-W, DiBaise JK., 2012. Effects of gut microbes on nutrient absorption and energy regulation. Nutr. Clin Pract. 27:201–214.
58. Kübeck R, Bonet-Ripoll C, Hoffmann C, Walker A, Müller VM, Schüppel VL, Lagkouvardos I, Scholz B, Engel K-H, Daniel H, et al. 2016. Dietary fat and gut microbiota interactions determine diet-induced obesity in mice. Mol Metab. 5:1162–1174.
59. Laugerette F, Vors C, Géloën A, Chauvin M-A, Soulage C, Lambert-Porcheron S, Peretti N, Alligier M, Burcelin R, Laville M, et al. 2011. Emulsified lipids increase endotoxemia: possible role in early postprandial low-grade inflammation. J Nutr Biochem. 22:53–59.
60. Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G, Almeida M, Arumugam M, Batto J-M, Kennedy S, et al. 2013. Richness of human gut microbiome correlates with metabolic markers. Nature. 500:541–546.
61. Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI., 2005. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA. 102:11070–11075.
62. Ley RE, Turnbaugh PJ, Klein S, Gordon JI., 2006. Microbial ecology: human gut microbes associated with obesity. Nature. 444:1022–1023.
63. Lichtenstein L, Mattijssen F, de Wit NJ, Georgiadi A, Hooiveld GJ, van der Meer R, He Y, Qi L, Koster A, Tamsma JT, et al. 2010. Angptl4 protects against severe pro-inflammatory effects of dietary saturated fat by inhibiting lipoprotein lipase-dependent uptake of fatty acids in mesenteric lymph node macrophages. Cell Metab. 12:580–592.
64. Ma J, Prince AL, Bader D, Hu M, Ganu R, Baquero K, Blundell P, Alan Harris R, Frias AE, Grove KL, et al. 2014. High-fat maternal diet during pregnancy persistently alters the offspring microbiome in a primate model. Nat Commun. 5:3889.
65. Marques TM, Wall R, O’sullivan O, Fitzgerald GF, Shanahan F, Quigley EM, Cotter PD, Cryan JF, Dinan TG, Ross RP, et al. 2015. Dietary trans-10, cis-12-conjugated linoleic acid alters fatty acid metabolism and microbiota composition in mice. Br J Nutr. 113:728–738.
66. Martín-Peláez S, Mosele JI, Pizarro N, Farràs M, de la Torre R, Subirana I, Pérez-Cano FJ, Castañer O, Solà R, Fernandez-Castillejo S, et al. 2015. Effect of virgin olive oil and thyme phenolic compounds on blood lipid profile: implications of human gut microbiota. Eur J Nutr.
67. Mattijssen F, Alex S, Swarts HJ, Groen AK, van Schothorst EM, Kersten S., 2014. Angptl4 serves as an endogenous inhibitor of intestinal lipid digestion. Mol Metab. 3:135–144.
68. Moreira APB, Texeira TFS, Ferreira AB, do Carmo Gouveia Peluzio M, de Cássia Gonçalves Alfenas R., 2012. Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia. Br J Nutr. 108:801–809.
69. Mowat AM, Agace WW., 2014. Regional specialization within the intestinal immune system. Nat Rev Immunol. 14:667–685.
70. Muccioli GG, Naslain D, Bäckhed F, Reigstad CS, Lambert DM, Delzenne NM, Cani PD., 2010. The endocannabinoid system links gut microbiota to adipogenesis. Mol Syst Biol. 6:392.
71. Mujico JR, Baccan GC, Gheorghe A, Díaz LE, Marcos A., 2013. Changes in gut microbiota due to supplemented fatty acids in diet-induced obese mice. Br J Nutr. 110:711–720.
72. Murphy EF, Cotter PD, Healy S, Marques TM, O’sullivan O, Fouhy F, Clarke SF, O'Toole PW, Quigley EM, Stanton C, et al. 2010. Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. Gut. 59:1635–1642.
73. Naidu AS, Bidlack WR, Clemens RA., 1999. Probiotic spectra of lactic acid bacteria (LAB). Crit Rev Food Sci Nutr. 39:13–126.
74. Núñez IN, Galdeano CM, de LeBlanc A, de M, Perdigón G., 2014. Evaluation of immune response, microbiota, and blood markers after probiotic bacteria administration in obese mice induced by a high-fat diet. Nutrition. 30:1423–1432.
75. Olefsky JM, Glass CK., 2010. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol. 72:219–246.
76. Osterberg KL, Boutagy NE, McMillan RP, Stevens JR, Frisard MI, Kavanaugh JW, Davy BM, Davy KP, Hulver MW., 2015. Probiotic supplementation attenuates increases in body mass and fat mass during high-fat diet in healthy young adults. Obesity (Silver Spring). 23:2364–2370.
77. Pagotto U, Marsicano G, Cota D, Lutz B, Pasquali R., 2006. The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocr Rev. 27:73–100.
78. Patterson E, O’ Doherty RM, Murphy EF, Wall R, O’ Sullivan O, Nilaweera K, Fitzgerald GF, Cotter PD, Ross RP, Stanton C, et al. 2014. Impact of dietary fatty acids on metabolic activity and host intestinal microbiota composition in C57BL/6J mice. Br J Nutr. 111:1–13.
79. Png CW, Lindén SK, Gilshenan KS, Zoetendal EG, McSweeney CS, Sly LI, McGuckin MA, Florin THJ., 2010. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol. 105:2420–2428.
80. Praveen Raj P, Gomes RM, Kumar S, Senthilnathan P, Karthikeyan P, Shankar A, Palanivelu C., 2015. The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians: “NASHOST” prospective observational trial. Surg Obes Relat Dis. 11:1315–1322.
81. Prince A, Ma J, Baquero K, Blundell P, Takahashi D, Grove K, Aagaard K., 2016. Probiotics alter the intestinal microbiome but do not prevent high fat diet dysbiosis in primates. Am J Obstet Gynecol. 214:S44.
82. Qiao Y, Sun J, Xia S, Li L, Li Y, Wang P, Shi Y, Le G., 2015. Effects of different Lactobacillus reuteri on inflammatory and fat storage in high-fat diet-induced obesity mice model. J Funct Foods. 14:424–434.
83. Raso GM, Simeoli R, Iacono A, Santoro A, Amero P, Paciello O, Russo R, D’Agostino G, Di Costanzo M, Canani RB, et al. 2014. Effects of a Lactobacillus paracasei B21060 based synbiotic on steatosis, insulin signaling and toll-like receptor expression in rats fed a high-fat diet. J Nutr Biochem. 25:81–90.
84. Remely M, Hippe B, Geretschlaeger I, Stegmayer S, Hoefinger I, Haslberger A., 2015. Increased gut microbiota diversity and abundance of Faecalibacterium prausnitzii and Akkermansia after fasting: a pilot study. Wien Klin Wochenschr. 127:394–398.
85. Rey FE, Gonzalez MD, Cheng J, Wu M, Ahern PP, Gordon JI., 2013. Metabolic niche of a prominent sulfate-reducing human gut bacterium. Proc Natl Acad Sci USA. 110:13582–13587.
86. Ríos-Covián D, Ruas-Madiedo P, Margolles A, Gueimonde M, De los Reyes-Gavilán CG, Salazar N., 2016. Intestinal short chain fatty acids and their link with diet and human health. Front Microbiol. 7:185.
87. Russell DA, Ross RP, Fitzgerald GF, Stanton C., 2011. Metabolic activities and probiotic potential of bifidobacteria. Int J Food Microbiol. 149:88–105.
88. Salonen A, de Vos WM., 2014. Impact of diet on human intestinal microbiota and health. Annu Rev Food Sci Technol. 5:239–262.
89. Santacruz A, Collado MC, García-Valdés L, Segura MT, Martín-Lagos JA, Anjos T, Martí-Romero M, Lopez RM, Florido J, Campoy C, et al. 2010. Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women. Br J Nutr. 104:83–92.
90. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS., 2006. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest. 116:3015–3025.
91. Simões CD, Maukonen J, Kaprio J, Rissanen A, Pietiläinen KH, Saarela M., 2013. Habitual dietary intake is associated with stool microbiota composition in monozygotic twins. J Nutr. 143:417–423.
92. Song M, Park S, Lee H, Min B, Jung S, Park S, Kim E, Oh S., 2015. Effect of Lactobacillus acidophilus NS1 on plasma cholesterol levels in diet-induced obese mice. J Dairy Sci. 98:1492–1501.
93. Suganami T, Mieda T, Itoh M, Shimoda Y, Kamei Y, Ogawa Y., 2007. Attenuation of obesity-induced adipose tissue inflammation in C3H/HeJ mice carrying a Toll-like receptor 4 mutation. Biochem Biophys Res Commun. 354:45–49.
94. Suganami T, Tanimoto-Koyama K, Nishida J, Itoh M, Yuan X, Mizuarai S, Kotani H, Yamaoka S, Miyake K, Aoe S, et al. 2007. Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler Thromb Vasc Biol. 27:84–91.
95. Sun CQ, O’connor CJ, Roberton AM., 2003. Antibacterial actions of fatty acids and monoglycerides against Helicobacter pylori. FEMS Immunol Med Microbiol. 36:9–17.
96. Sun J, Qiao Y, Qi C, Jiang W, Xiao H, Shi Y, Le G-W., 2016. High-fat-diet-induced obesity is associated with decreased antiinflammatory Lactobacillus reuteri sensitive to oxidative stress in mouse Peyer’s patches. Nutrition. 32:265–272.
97. Suzuki T, Hara H., 2010. Dietary fat and bile juice, but not obesity, are responsible for the increase in small intestinal permeability induced through the suppression of tight junction protein expression in LETO and OLETF rats. Nutr Metab (Lond). 7:19.
98. Swidsinski A, Loening-Baucke V, Theissig F, Engelhardt H, Bengmark S, Koch S, Lochs H, Dörffel Y., 2007. Comparative study of the intestinal mucus barrier in normal and inflamed colon. Gut. 56:343–350.
99. Tabas I, Glass CK., 2013. Anti-inflammatory therapy in chronic disease: challenges and opportunities. Science. 339:166–172.
100. Tagliabue A, Elli M., 2013. The role of gut microbiota in human obesity: recent findings and future perspectives. Nutr Metab Cardiovasc Dis NMCD. 23:160–168.
101. Tappy L., 2004. Metabolic consequences of overfeeding in humans. Curr Opin Clin Nutr Metab Care. 7:623–628.
102. Tremaroli V, Bäckhed F., 2012. Functional interactions between the gut microbiota and host metabolism. Nature. 489:242–249.
103. Turnbaugh PJ, Bäckhed F, Fulton L, Gordon JI., 2008. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe. 3:213–223.
104. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, Sogin ML, Jones WJ, Roe BA, Affourtit JP, et al. 2009. A core gut microbiome in obese and lean twins. Nature. 457:480–484.
105. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI., 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 444:1027–1131.
106. Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI., 2009. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med. 1:6ra14.
107. Wall R, Ross RP, Fitzgerald GF, Stanton C., 2010. Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids. Nutr Rev. 68:280–289.
108. Wang J, Tang H, Zhang C, Zhao Y, Derrien M, Rocher E, van-Hylckama Vlieg JET, Strissel K, Zhao L, Obin M, et al. 2015. Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice. ISME J. 9:1–15.
109. Weglarz L, Dzierzewicz Z, Skop B, Orchel A, Parfiniewicz B, Wiśniowska B, Swiatkowska L, Wilczok T., 2003. Desulfovibrio desulfuricans lipopolysaccharides induce endothelial cell IL-6 and IL-8 secretion and E-selectin and VCAM-1 expression. Cell Mol Biol Lett. 8:991–1003.
110. Weingarden A, González A, Vázquez-Baeza Y, Weiss S, Humphry G, Berg-Lyons D, Knights D, Unno T, Bobr A, Kang J, et al. 2015. Dynamic changes in short- and long-term bacterial composition following fecal microbiota transplantation for recurrent Clostridium difficile infection. Microbiome. 3:10.
111. Wille JJ, Kydonieus A., 2003. Palmitoleic acid isomer (C16:1delta6) in human skin sebum is effective against gram-positive bacteria. Skin Pharmacol Appl Skin Physiol. 16:176–187.
112. Wu C-C, Weng W-L, Lai W-L, Tsai H-P, Liu W-H, Lee M-H, Tsai Y-C., 2015. Effect of Lactobacillus plantarum strain K21 on high-fat diet-fed obese mice, effect of Lactobacillus plantarum strain K21 on high-fat diet-fed obese mice. Evid Based Complement Altern Med. 2015:e391767.
113. Wu GD, Chen J, Hoffmann C, Bittinger K, Chen Y-Y, Keilbaugh SA, Bewtra M, Knights D, Walters WA, Knight R, et al. 2011. Linking long-term dietary patterns with gut microbial enterotypes. Science. 334:105–108.
114. Yin Y-N, Yu Q-F, Fu N, Liu X-W, Lu F-G., 2010. Effects of four Bifidobacteria on obesity in high-fat diet induced rats. World J Gastroenterol. 16:3394–3401.
115. Yoo J, Kim S., 2016. Probiotics and prebiotics: present status and future perspectives on metabolic disorders. Nutrients. 8:173.
116. Zhang C, Zhang M, Wang S, Han R, Cao Y, Hua W, Mao Y, Zhang X, Pang X, Wei C, et al. 2010. Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice. ISME J. 4:232–241.
117. Zhang H, DiBaise JK, Zuccolo A, Kudrna D, Braidotti M, Yu Y, Parameswaran P, Crowell MD, Wing R, Rittmann BE, et al. 2009. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci USA. 106:2365–2370.
118. Zheng CJ, Yoo J-S, Lee T-G, Cho H-Y, Kim Y-H, Kim W-G., 2005. Fatty acid synthesis is a target for antibacterial activity of unsaturated fatty acids. FEBS Lett. 579:5157–5162.
119. Zhou J, Martin RJ, Tulley RT, Raggio AM, McCutcheon KL, Shen L, Danna SC, Tripathy S, Hegsted M, Keenan MJ, et al. 2008. Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents. Am J Physiol Endocrinol Metab. 295:E1160–E1166.